Aardvark Therapeutics, Inc. Common Stock ( AARD) - Key Metrics
AARD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.66 | -$0.81 | -$0.81 |
| 2026Q1 | $0 | -$0.99 | -$0.86 | -$0.86 |
| 2025Q4 | $0 | -$0.81 | -$0.66 | -$0.66 |
| 2025Q3 | $0 | -$0.75 | -$0.85 | -$0.85 |
| 2025Q2 | $0 | -$0.66 | -$0.45 | -$0.46 |
AARD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.18 |
| 2026Q1 | 0% | -0.95 |
| 2025Q4 | 0% | -4.05 |
| 2025Q3 | 0% | -4.43 |
| 2025Q2 | 0% | -5.12 |
AARD
Price: $6.82
52 week price:
Earnings Per Share: -2.95 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 134.5 million